Survival	B:C0038953
of	O
ovarian	B:C0029925
cancer	I:C0029925
patients	O
in	O
Denmark	B:C0011318
:	O
Results	O
from	O
the	O
Danish	B:C1707252
gynaecological	I:C1707252
cancer	I:C1707252
group	I:C1707252
(	B:C1140271
DGCG	I:C1140271
)	I:C1140271
database	I:C1140271
,	O
1995	O
-	O
2012	O
.	O

Ovarian	B:C0029925
cancer	I:C0029925
has	O
a	O
high	O
mortality	O
rate	O
,	O
especially	O
in	O
Denmark	B:C0011318
where	O
mortality	O
rates	O
have	O
been	O
reported	O
higher	O
than	O
in	O
adjacent	B:C0454664
countries	I:C0454664
with	O
similar	O
demographics	O
.	O

This	O
study	O
therefore	O
examined	O
recent	O
survival	O
and	O
mortality	O
among	O
Danish	B:C0029925
ovarian	I:C0029925
cancer	I:C0029925
patients	O
over	O
an	O
18	O
-	O
year	O
study	O
period	O
.	O

This	O
nationwide	B:C1514227
registry	I:C1514227
-	I:C1514227
based	I:C1514227
observational	B:C1518527
study	I:C1518527
used	O
data	O
from	O
the	O
Danish	B:C1140271
Gynecology	I:C1140271
Cancer	I:C1140271
Database	I:C1140271
,	O
Danish	O
Pathology	O
Registry	O
,	O
and	O
Danish	B:C0920631
National	I:C0920631
Patient	I:C0920631
Registry	I:C0920631
.	O

All	O
patients	O
with	O
ovarian	B:C0029925
cancer	I:C0029925
diagnosed	B:C0920688
between	O
1995	O
and	O
2012	O
were	O
included	O
in	O
the	O
study	O
.	O

The	O
data	O
sources	O
were	O
linked	O
via	O
the	O
patients	O
'	O
personal	B:C0242471
identification	I:C0242471
number	I:C0242471
and	O
the	O
analyses	O
included	O
data	O
on	O
cancer	B:C0027646
stage	I:C0027646
,	O
age	O
,	O
survival	B:C0038953
,	O
surgery	O
status	O
and	O
comorbidity	O
.	O

We	O
identified	O
9972	O
patients	O
diagnosed	O
with	O
ovarian	B:C0029925
cancer	I:C0029925
in	O
the	O
period	O
1995	O
-	O
2012	O
.	O

After	O
stratification	B:C1514983
by	I:C1514983
age	I:C1514983
,	O
comorbidity	O
and	O
cancer	B:C0027646
stage	I:C0027646
,	O
the	O
decrease	O
in	O
one	O
-	O
year	O
mortality	O
was	O
most	O
substantial	O
in	O
the	O
65	O
-	O
74	O
year	O
old	B:C1999167
age	I:C1999167
group	I:C1999167
41.1	O
(	O
CI	O
38.8	O
-	O
43.5	O
)	O
to	O
26.5	O
(	O
CI	O
24.4-28.7	O
)	O
and	O
for	O
stage	B:C0278687
III	I:C0278687
39.1	O
(	O
CI	O
35.1	O
-	O
43.6	O
)	O
to	O
22.9	O
(	O
CI	O
19.9	O
-	O
26.5	O
)	O
and	O
stage	B:C2217303
IV	I:C2217303
91.3	O
(	O
CI	O
80.8	O
-	O
103.2	O
)	O
to	O
41.9	O
(	O
CI	O
35.5-49.5	O
)	O
.	O

Ovarian	B:C0029925
cancer	I:C0029925
survival	O
in	O
Denmark	B:C0011318
has	O
improved	O
substantially	O
from	O
1995	O
to	O
2012	O
,	O
bringing	O
Denmark	B:C0011318
closer	O
to	O
the	O
standards	O
set	O
by	O
adjacent	B:C0454664
countries	I:C0454664
.	O

